About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2018 ASTRO Annual Meeting
ESMO 2018 Congress
IASLC 19th World Conference on Lung Cancer
Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
2018 ASCO Annual Meeting
Methotrexate–Induced Kidney Injury
IMPROVING NSCLC OUTCOMES
2016 International Head and Neck Conference
Today In Oncology
FDA Pipeline: What’s New in Biosimilars, Drug Reviews, Designations, and More
Transcription Factors TP63 and SOX2 in Squamous Cell Carcinoma Progression
Molecular and Clinical Heterogeneity in Histologically Diagnosed CNS-PNET
PERSIST-5: 5-Year Adjuvant Imatinib in Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor
Patient-Reported Cosmetic Outcomes With Radiotherapy in Early Breast Cancer
Most Read Stories
FDA Approves Pembrolizumab for Hepatocellular Carcinoma Previously Treated With a Kinase Inhibitor
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
COMBI-AD Trial: Longer-Term Follow-up of Adjuvant Dabrafenib Plus Trametinib in Resected
V600–Mutant Stage III Melanoma
Has the Promise of Precision Medicine Been Oversold?
Trifluridine/Tipiracil in Heavily Pretreated Metastatic Gastric Cancer
Most Viewed Videos
Laurence Albiges, MD, PhD, on RCC: Challenging Established Front-Line Treatment
David Palma, MD, PhD, on Oligometastatic Tumors: Results From the SABR-COMET Trial
Ezra E.W. Cohen, MD, on Head and Neck Cancer: Using Curative Immunotherapy
Lisa A. Carey, MD, and Sherene Loi, MD, PhD, on TNBC: Combination Immune Checkpoint Inhibitor Therapy
Caroline Robert, MD, PhD, on Advanced Melanoma: Research Highlights
© 2018 HSP News Service, L.L.C.
to learn more.